Tau in physiology and pathology

Tau is a microtubule-associated protein that has a role in stabilizing neuronal microtubules and thus in promoting axonal outgrowth. Structurally, tau is a natively unfolded protein, is highly soluble and shows little tendency for aggregation. However, tau aggregation is characteristic of several neurodegenerative diseases known as tauopathies. The mechanisms underlying tau pathology and tau-mediated neurodegeneration are debated, but considerable progress has been made in the field of tau research in recent years, including the identification of new physiological roles for tau in the brain. Here, we review the expression, post-translational modifications and functions of tau in physiology and in pathophysiology.

[1]  Akihiko Takashima,et al.  Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer's Disease , 2004, The Journal of Neuroscience.

[2]  E. Mandelkow,et al.  Amyloid‐β oligomers induce synaptic damage via Tau‐dependent microtubule severing by TTLL6 and spastin , 2013, The EMBO journal.

[3]  N. Hirokawa,et al.  Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons , 1996, The Journal of cell biology.

[4]  E. Mandelkow,et al.  Missorting of Tau in Neurons Causes Degeneration of Synapses That Can Be Rescued by the Kinase MARK2/Par-1 , 2007, The Journal of Neuroscience.

[5]  Hyonchol Kim,et al.  Granular tau oligomers as intermediates of tau filaments. , 2007, Biochemistry.

[6]  M. Diamond,et al.  Prion-like Properties of Tau Protein: The Importance of Extracellular Tau as a Therapeutic Target* , 2014, The Journal of Biological Chemistry.

[7]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .

[8]  P. Lopresti,et al.  Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Rudi D'Hooge,et al.  Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant , 2011, The Journal of Neuroscience.

[10]  B. Dubois,et al.  A phase II trial of tideglusib in Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[11]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[12]  Aidong Yuan,et al.  Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice , 2008, The Journal of Neuroscience.

[13]  E. Mandelkow,et al.  Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons , 2007, The Journal of Neuroscience.

[14]  E. Sigurdsson.  Tau Immunotherapy and Imaging , 2013, Neurodegenerative Diseases.

[15]  J. Brion,et al.  Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer , 1985 .

[16]  J. Brion,et al.  Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's disease , 2004, FEBS letters.

[17]  R. Staff,et al.  Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.

[18]  E. Mandelkow,et al.  Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. , 2012, Human molecular genetics.

[19]  G. Höglinger,et al.  Mitochondrial Complex 1 Inhibition Increases 4-Repeat Isoform Tau by SRSF2 Upregulation , 2014, PloS one.

[20]  A. Goate,et al.  Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies* , 2012, The Journal of Biological Chemistry.

[21]  E. Mandelkow,et al.  Inducible Expression of Tau Repeat Domain in Cell Models of Tauopathy , 2006, Journal of Biological Chemistry.

[22]  W. Noble,et al.  Molecular motors implicated in the axonal transport of tau and α-synuclein , 2005, Journal of Cell Science.

[23]  J. Walker,et al.  Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Bush,et al.  Motor and cognitive deficits in aged tau knockout mice in two background strains , 2014, Molecular Neurodegeneration.

[25]  J. Trojanowski,et al.  Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.

[26]  A. Nappi,et al.  Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .

[27]  H. Band,et al.  Tau interacts with src-family non-receptor tyrosine kinases. , 1998, Journal of cell science.

[28]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[29]  I. Grundke‐Iqbal,et al.  Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5 , 2002, Neuroscience.

[30]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[31]  M. Vitek,et al.  Function of tau protein in adult newborn neurons , 2009, FEBS letters.

[32]  G. Collingridge,et al.  Microtubule-associated protein tau is essential for long-term depression in the hippocampus , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[33]  Heiko Meyer,et al.  RNA Protein Granules Modulate tau Isoform Expression and Induce Neuronal Sprouting* , 2014, The Journal of Biological Chemistry.

[34]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology , 1987 .

[35]  J. Bamburg,et al.  Activated Actin-Depolymerizing Factor/Cofilin Sequesters Phosphorylated Microtubule-Associated Protein during the Assembly of Alzheimer-Like Neuritic Cytoskeletal Striations , 2009, The Journal of Neuroscience.

[36]  C. White,et al.  Downregulation of Protein Phosphatase 2A Carboxyl Methylation and Methyltransferase May Contribute to Alzheimer Disease Pathogenesis , 2004, Journal of neuropathology and experimental neurology.

[37]  G. Schellenberg,et al.  SUT-1 enables tau-induced neurotoxicity in C. elegans. , 2007, Human molecular genetics.

[38]  Clifford R Jack,et al.  Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial , 2014, The Lancet Neurology.

[39]  Tudor A. Fulga,et al.  Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo , 2007, Nature Cell Biology.

[40]  B. Hyman,et al.  Caspase activation precedes and leads to tangles , 2010, Nature.

[41]  M. Goedert,et al.  Interaction of tau protein with the dynactin complex , 2007, The EMBO journal.

[42]  J. Barg,et al.  Subcellular localization of tau mRNA in differentiating neuronal cell culture: Implications for neuronal polarity , 1993, Neuron.

[43]  E. Sigurdsson,et al.  Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance* , 2013, The Journal of Biological Chemistry.

[44]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[45]  I. Grundke‐Iqbal,et al.  Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.

[46]  S. Younkin,et al.  Tau Loss Attenuates Neuronal Network Hyperexcitability in Mouse and Drosophila Genetic Models of Epilepsy , 2013, The Journal of Neuroscience.

[47]  Q. Tian,et al.  Essential role of tau phosphorylation in adult hippocampal neurogenesis , 2010, Hippocampus.

[48]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[49]  J. Trojanowski,et al.  Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau , 1994, Neuron.

[50]  J. Ávila,et al.  Tau isoform with three microtubule binding domains is a marker of new axons generated from the subgranular zone in the hippocampal dentate gyrus: implications for Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[51]  P. Filipcik,et al.  Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo , 2006, FEBS letters.

[52]  L. Mucke,et al.  Tau Reduction Prevents Disease in a Mouse Model of Dravet Syndrome , 2014, Annals of neurology.

[53]  R. Maccioni,et al.  Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization , 2006, Journal of Cell Science.

[54]  L. Buée,et al.  Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms , 2015, Scientific Reports.

[55]  T. Morita,et al.  1 Specification of neuronal polarity regulated by local translation of CRMP 2 and tau via the mTOR-p 70 S 6 K pathway , 2009 .

[56]  R. Morimoto,et al.  Proteostasis and the aging proteome in health and disease. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[57]  G. Schellenberg,et al.  SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. , 2009, Human molecular genetics.

[58]  Ann C. McKee,et al.  Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy , 2015, Nature.

[59]  E. Haan,et al.  SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease , 2003, Experimental Neurology.

[60]  W. Noble,et al.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.

[61]  G. Hart,et al.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[62]  E. Mandelkow,et al.  Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration , 2011, The EMBO journal.

[63]  P. Davies,et al.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.

[64]  K. Titani,et al.  Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments , 1992 .

[65]  E. Mandelkow,et al.  Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.

[66]  Henning Urlaub,et al.  Tau stabilizes microtubules by binding at the interface between tubulin heterodimers , 2015, Proceedings of the National Academy of Sciences.

[67]  T. Arendt,et al.  Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability* , 2012, The Journal of Biological Chemistry.

[68]  J. Trojanowski,et al.  Therapeutic strategies for tau mediated neurodegeneration , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[69]  H. Mori,et al.  Isoforms changes of tau protein during development in various species. , 2003, Brain research. Developmental brain research.

[70]  J. Trojanowski,et al.  Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice , 2015, Neurobiology of Disease.

[71]  N. Leclerc,et al.  Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation* , 2012, The Journal of Biological Chemistry.

[72]  A. Borreca,et al.  NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease. , 2015, Human molecular genetics.

[73]  L. Buée,et al.  A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions , 2014, Front. Cell. Neurosci..

[74]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[75]  B. Hyman,et al.  Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease , 2014, Acta Neuropathologica Communications.

[76]  D. Holtzman,et al.  Antisense Reduction of Tau in Adult Mice Protects against Seizures , 2013, The Journal of Neuroscience.

[77]  S. Gygi,et al.  Why do cellular proteins linked to K63‐polyubiquitin chains not associate with proteasomes? , 2013, The EMBO journal.

[78]  Jeff Kuret,et al.  Two motifs within the tau microtubule‐binding domain mediate its association with the hsc70 molecular chaperone , 2008, Journal of neuroscience research.

[79]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[80]  Allissa Dillman,et al.  MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies , 2012, Human molecular genetics.

[81]  I. Grundke‐Iqbal,et al.  Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain , 1993, Journal of neurochemistry.

[82]  H. Steinhoff,et al.  Global hairpin folding of tau in solution. , 2006, Biochemistry.

[83]  Stefani N. Thomas,et al.  Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity. , 2014, The Biochemical journal.

[84]  V. Lee,et al.  The microtubule-associated tau protein has intrinsic acetyltransferase activity , 2013, Nature Structural &Molecular Biology.

[85]  D. Rubinsztein,et al.  Rapamycin alleviates toxicity of different aggregate-prone proteins. , 2006, Human molecular genetics.

[86]  Helmut Grubmüller,et al.  Molecular Anatomy of a Trafficking Organelle , 2006, Cell.

[87]  E. Mandelkow,et al.  Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. , 2009, Human molecular genetics.

[88]  J. Ávila,et al.  Characteristics and consequences of muscarinic receptor activation by tau protein , 2009, European Neuropsychopharmacology.

[89]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[90]  J. Trojanowski,et al.  Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy , 2010, The Journal of Neuroscience.

[91]  V. Lee,et al.  Seeding of Normal Tau by Pathological Tau Conformers Drives Pathogenesis of Alzheimer-like Tangles* , 2011, The Journal of Biological Chemistry.

[92]  E. Mandelkow,et al.  Degradation of tau protein by autophagy and proteasomal pathways. , 2012, Biochemical Society transactions.

[93]  C. Haass,et al.  Loss of fused in sarcoma (FUS) promotes pathological Tau splicing , 2012, EMBO reports.

[94]  L. Binder,et al.  Identification of nuclear tau isoforms in human neuroblastoma cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[95]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[96]  R. D'Hooge,et al.  Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion , 2014, Neurobiology of Aging.

[97]  M. Zvelebil,et al.  Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases* , 2008, Journal of Biological Chemistry.

[98]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[99]  M. W. Wooten,et al.  Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation , 2005, Journal of neurochemistry.

[100]  R. Neve,et al.  Tau in situ hybridization in normal and alzheimer brain: Localization in the somatodendritic compartment , 1989, Annals of neurology.

[101]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[102]  E. Mandelkow,et al.  Oligomer Formation of Tau Protein Hyperphosphorylated in Cells* , 2014, The Journal of Biological Chemistry.

[103]  M. Shelanski,et al.  tau Regulation of microtubule-microtubule spacing and bundling. , 1994, Journal of neurochemistry.

[104]  B. C. Carter,et al.  Multiple-motor based transport and its regulation by Tau , 2007, Proceedings of the National Academy of Sciences.

[105]  Abeta oligomers cause local missorting of endogenous tau into dendrites, tau phosphorylation, destruction of microtubules and spines , 2010, Alzheimer's & Dementia.

[106]  J. Trojanowski,et al.  Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia , 2001, Annals of neurology.

[107]  J. Ávila,et al.  Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells , 2008, Molecular and Cellular Neuroscience.

[108]  F. Terro,et al.  Post-translational modifications of tau protein: Implications for Alzheimer's disease , 2011, Neurochemistry International.

[109]  M. Caldara,et al.  Tau Monoclonal Antibody Generation Based on Humanized Yeast Models , 2014, The Journal of Biological Chemistry.

[110]  K. Ashe,et al.  Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration , 2010, Neuron.

[111]  Tsuyoshi Morita,et al.  Specification of Neuronal Polarity Regulated by Local Translation of CRMP2 and Tau via the mTOR-p70S6K Pathway* , 2009, The Journal of Biological Chemistry.

[112]  A. Borreca,et al.  NH 2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1 : implications in Alzheimer ’ s disease , 2015 .

[113]  Xinglong Wang,et al.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. , 2013, Free radical biology & medicine.

[114]  M. Kirschner,et al.  The primary structure and heterogeneity of tau protein from mouse brain. , 1988, Science.

[115]  R. Nelson,et al.  Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia , 2007, The Journal of Neuroscience.

[116]  P. Davies,et al.  Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity , 2013, PloS one.

[117]  Klaus-Armin Nave,et al.  Myelination of the nervous system: mechanisms and functions. , 2014, Annual review of cell and developmental biology.

[118]  J. Trojanowski,et al.  Acetylated tau neuropathology in sporadic and hereditary tauopathies. , 2013, The American journal of pathology.

[119]  Phillip B. Jones,et al.  In Vivo Imaging Reveals Dissociation between Caspase Activation and Acute Neuronal Death in Tangle-Bearing Neurons , 2008, The Journal of Neuroscience.

[120]  Thomas Tuschl,et al.  Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. , 2015, The Journal of clinical investigation.

[121]  I. Landrieu,et al.  Immunophilin FKBP52 induces Tau-P301L filamentous assembly in vitro and modulates its activity in a model of tauopathy , 2014, Proceedings of the National Academy of Sciences.

[122]  G. Drewes,et al.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.

[123]  Jason T. Stevens,et al.  Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation , 2011, Nature.

[124]  M. Kidd.  Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.

[125]  Wolfgang Härtig,et al.  Reversible Paired Helical Filament-Like Phosphorylation of Tau Is an Adaptive Process Associated with Neuronal Plasticity in Hibernating Animals , 2003, The Journal of Neuroscience.

[126]  L. Grinberg,et al.  Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies , 2014, Neuron.

[127]  M. Goedert,et al.  Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice , 2013, Acta Neuropathologica.

[128]  I. Grundke‐Iqbal,et al.  Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[129]  R. D'Hooge,et al.  Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau , 2012, Acta Neuropathologica.

[130]  R. Berry,et al.  Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo , 2006, Journal of neurochemistry.

[131]  K. Jellinger,et al.  PART, a distinct tauopathy, different from classical sporadic Alzheimer disease , 2015, Acta Neuropathologica.

[132]  E. Mandelkow,et al.  Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau , 2015, Acta neuropathologica communications.

[133]  D. Holtzman,et al.  Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.

[134]  Alexandra Flemming,et al.  Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.

[135]  E. Mandelkow,et al.  Autophagic degradation of tau in primary neurons and its enhancement by trehalose , 2012, Neurobiology of Aging.

[136]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[137]  K. Ye,et al.  SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination , 2014, Proceedings of the National Academy of Sciences.

[138]  W. Nickel,et al.  Mechanisms of regulated unconventional protein secretion , 2009, Nature Reviews Molecular Cell Biology.

[139]  J. Ávila,et al.  Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers , 2004, Neuroscience Letters.

[140]  D. Holtzman,et al.  Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo , 2013, Neuron.

[141]  L. Buée,et al.  MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy , 2011, Alzheimer's & Dementia.

[142]  J. Götz,et al.  Profiling Murine Tau with 0N, 1N and 2N Isoform-Specific Antibodies in Brain and Peripheral Organs Reveals Distinct Subcellular Localization, with the 1N Isoform Being Enriched in the Nucleus , 2013, PloS one.

[143]  L. Buée,et al.  Nuclear Tau, a Key Player in Neuronal DNA Protection* , 2010, The Journal of Biological Chemistry.

[144]  L. Kappos,et al.  Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice , 2013, PloS one.

[145]  Leslie Wilson,et al.  Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death. , 2005, Biochimica et biophysica acta.

[146]  Ram Dixit,et al.  Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.

[147]  N. Krogan,et al.  Critical Role of Acetylation in Tau-Mediated Neurodegeneration and Cognitive Deficits , 2015, Nature Medicine.

[148]  H. Nagaraja,et al.  Tau Isoform Composition Influences Rate and Extent of Filament Formation* , 2012, The Journal of Biological Chemistry.

[149]  L. McIntosh,et al.  O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers. , 2014, Journal of molecular biology.

[150]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[151]  D. Dickson,et al.  Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. , 2009, The American journal of pathology.

[152]  Blaine R. Roberts,et al.  Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export , 2012, Nature Medicine.

[153]  V. Laporte,et al.  Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. , 2012, The American journal of pathology.

[154]  I. Grundke‐Iqbal,et al.  I 1 PP 2 A Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2 A * , 2008 .

[155]  John Hardy,et al.  CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation , 2004 .

[156]  E. Mandelkow,et al.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[157]  K. Kosik,et al.  Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons , 1990, Nature.

[158]  J. Zweier,et al.  Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide , 1995, Nature Medicine.

[159]  M. Sierks,et al.  Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations , 2013, International journal of cell biology.

[160]  H. Huppertz,et al.  Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial , 2014, Movement disorders : official journal of the Movement Disorder Society.

[161]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[162]  J. Walker,et al.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[163]  William T. Hu,et al.  Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease , 2014, Nature Medicine.

[164]  Clemens F. Kaminski,et al.  Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology* , 2013, The Journal of Biological Chemistry.

[165]  Steven P. Gygi,et al.  CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival* , 2004, Journal of Biological Chemistry.

[166]  J. Götz,et al.  Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease* , 2009, The Journal of Biological Chemistry.

[167]  F. Brodsky,et al.  Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds , 2013, Proceedings of the National Academy of Sciences.

[168]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[169]  T. Golde.  Open questions for Alzheimer’s disease immunotherapy , 2014, Alzheimer's Research & Therapy.

[170]  P. Fraser,et al.  Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein* , 2006, Journal of Biological Chemistry.

[171]  Dennis W. Dickson,et al.  Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau) , 2011, Journal of Molecular Neuroscience.

[172]  Douglas Galasko,et al.  The τ Protein in Human Cerebrospinal Fluid in Alzheimer's Disease Consists of Proteolytically Derived Fragments , 1997, Journal of neurochemistry.

[173]  K. Titani,et al.  Fetal-type phosphorylation of the tau in paired helical filaments. , 1992, Journal of neurochemistry.

[174]  E. Mandelkow,et al.  The fuzzy coat of pathological human Tau fibrils is a two-layered polyelectrolyte brush , 2012, Proceedings of the National Academy of Sciences.

[175]  C. Geula,et al.  Selective tau tyrosine nitration in non-AD tauopathies , 2011, Acta Neuropathologica.

[176]  Guixiang Xu,et al.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. , 2015, Brain : a journal of neurology.

[177]  E. Mandelkow,et al.  Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. , 2002, Molecular biology of the cell.

[178]  Y. Ihara,et al.  Molecular aging of tau: disulfide‐independent aggregation and non‐enzymatic degradation in vitro and in vivo , 2004, Journal of neurochemistry.

[179]  I. Grundke‐Iqbal,et al.  I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A* , 2008, Journal of Biological Chemistry.

[180]  C. Duijn,et al.  High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.

[181]  U. Sengupta,et al.  Identification of oligomers at early stages of tau aggregation in Alzheimer's disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[182]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[183]  L. Petrucelli,et al.  Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration , 2014, Acta Neuropathologica.

[184]  Michelle K. Lupton,et al.  Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. , 2012, Human molecular genetics.

[185]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[186]  N. Hirokawa,et al.  Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons , 1992, Nature.

[187]  Khadija Iqbal,et al.  Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. , 1993, The Journal of biological chemistry.

[188]  E. Mandelkow,et al.  Hsp90-Tau Complex Reveals Molecular Basis for Specificity in Chaperone Action , 2014, Cell.

[189]  A. Andreadis,et al.  Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases , 2011, The Journal of Neuroscience.

[190]  H. Braak,et al.  Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process? , 2014, Acta Neuropathologica.

[191]  P. Hof,et al.  Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms , 2005, The Journal of Neuroscience.

[192]  E. Mandelkow,et al.  RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments , 1996, FEBS letters.

[193]  U. Sengupta,et al.  Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles , 2014, The Journal of Neuroscience.

[194]  S. Yen,et al.  Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau* , 2005, Journal of Biological Chemistry.

[195]  L. Binder,et al.  Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.

[196]  C. Dickey,et al.  Targeting Hsp90 and its co-chaperones to treat Alzheimer’s disease , 2014, Expert opinion on therapeutic targets.

[197]  E. Mandelkow,et al.  Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. , 1999, Biochemistry.

[198]  Meaghan Morris,et al.  Tau post-translational modifications in wildtype and human amyloid precursor protein transgenic mice , 2015, Nature Neuroscience.

[199]  L. Behar,et al.  Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal , 2001, The Journal of Neuroscience.

[200]  P. Coleman,et al.  Neurons may live for decades with neurofibrillary tangles. , 1999, Journal of neuropathology and experimental neurology.

[201]  Casey Cook,et al.  Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance , 2013, Human molecular genetics.

[202]  Wendy Noble,et al.  Physiological release of endogenous tau is stimulated by neuronal activity , 2013, EMBO reports.

[203]  Hermann Bujard,et al.  The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy* , 2007, Journal of Biological Chemistry.

[204]  Ewa A. Mirecka,et al.  Alternative Conformations of the Tau Repeat Domain in Complex with an Engineered Binding Protein* , 2014, The Journal of Biological Chemistry.

[205]  L. Collin,et al.  Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease. , 2014, Brain : a journal of neurology.

[206]  J. Ávila,et al.  τ Protein from Alzheimer's Disease Patients Is Glycated at Its Tubulin‐Binding Domain , 1995, Journal of neurochemistry.

[207]  R. Neve,et al.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. , 1986, Brain research.

[208]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.

[209]  E. Mandelkow,et al.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.

[210]  M. Frotscher,et al.  Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca++ dysregulation , 2015, Acta Neuropathologica Communications.

[211]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[212]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[213]  Ayodeji A. Asuni,et al.  Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements , 2007, The Journal of Neuroscience.

[214]  I. Ferrer,et al.  Huntington's disease is a four-repeat tauopathy with tau nuclear rods , 2014, Nature Medicine.

[215]  Janna H. Neltner,et al.  Primary age-related tauopathy (PART): a common pathology associated with human aging , 2014, Acta Neuropathologica.

[216]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[217]  D. Holtzman,et al.  In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice , 2011, The Journal of Neuroscience.

[218]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[219]  A. Andreadis.  Misregulation of tau alternative splicing in neurodegeneration and dementia. , 2006, Progress in molecular and subcellular biology.

[220]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[221]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[222]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[223]  A. Buisson,et al.  Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers , 2014, The Journal of Neuroscience.

[224]  Christian Griesinger,et al.  Structural Polymorphism of 441-Residue Tau at Single Residue Resolution , 2009, PLoS biology.

[225]  E. Yaksi,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[226]  Irving E. Vega,et al.  Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. , 2005, Brain research. Molecular brain research.

[227]  E. Mandelkow,et al.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model , 2007, Proceedings of the National Academy of Sciences.